Mechanisms of Disease: biomarkers and molecular targets from microarray gene expression studies in prostate cancer
Colin S Cooper*, Colin Campbell and Sameer Jhavar
Correspondence *Male Urological Cancer Research Centre, Institute of Cancer Research, 15 Cotswold Road, Belmont, Sutton, Surrey SM2 5NG, UK
Email colin.cooper@icr.ac.uk
Current tests for the initial diagnosis of prostate cancer have limited sensitivity and specificity, and new biomarkers are being investigated. This Review discusses the use of molecular techniques for research into gene expression in prostate cancer and the biomarkers identified that could prove to be useful in the diagnosis and categorization of prostate cancer.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Integrative molecular concept modeling of prostate cancer progressionNature Genetics Article (01 Jan 2007)
Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimensProstate Cancer and Prostatic Diseases Original Article
Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimensProstate Cancer and Prostatic Diseases Original Article